Back
 

View:
Mini 
BasicThis view is available after user registration.
 
ShortThis view is available when you buy a license.
 
StandardThis view is available when you buy a license.
 
CompleteThis view is available when you buy a license.
 

Durvalumab 1500 / Tarlatamab (1/10), Small Cell Lung Cancer, Cycle 1

Protocol-ID: 3284 V1.0 (Mini), DURV1500/TARL(1/10), SCLC, C1

Indication(s)

  • Lung Carcinoma, Small Cell; ICD-10 C34.-
The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician.

Valid since: 17.11.2026